| AXSOME THERAPEUT. DL-0001 |
| USA |
| Gesundheit |
| US05464T1043 / A2AA7B |
| 19X (Frankfurt) / AXSM (NASDAQ) |
| FRA:19X, ETR:19X, 19X:GR, NASDAQ:AXSM |
| - |
| https://axsome.com/ |
|
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on developing and marketing therapies for central nervous system conditions with limited treatment options. Headquartered in New York City and founded in 2012, the comp..
>Volltext.. |
| 9471.43 Mio. EUR |
| 9397.93 Mio. EUR |
| 612.74 Mio. EUR |
| -144.79 Mio. EUR |
| -162.91 Mio. EUR |
| -3.24 EUR |
| 190.25 Mio. EUR |
| 263.97 Mio. EUR |
| -61.19 Mio. EUR |
| 0.69 |
| 53.46% |
| 36.64% |
| - |
| - |
| - |
| AXSOME |
| 10.08.26 |
|
||||
|
||||
|
||||
|